Transcranial Magnetic Stimulation–Assisted Psychotherapy (TAP): Toward a Paradigm Shift

Abstract
Background: Transcranial magnetic stimulation (TMS) and psychotherapy each help subsets of patients, yet outcomes remain variable when used alone. Targeted neuromodulation may transiently enhance neuroplasticity relevant to therapeutic learning and, when integrated developmentally, may support longer-arc change.
Objective: To propose Transcranial Magnetic Stimulation–Assisted Psychotherapy (TAP), a framework integrating repetitive TMS (rTMS) with mechanism- and network-aligned psychotherapy and selected adjuncts to improve efficacy, personalization, durability, and developmental impact.
Methods: Narrative synthesis of evidence on rTMS mechanisms, psychotherapy processes, timing-dependent plasticity, large-scale brain networks, and early combined-modality studies. We outline a phased workflow (including optional retreatment), timing/dose parameters, outcomes, biomarkers, and safety/training needs.
Results: TAP comprises four phases: (1) preparation/personalization (phenotyping, connectivity-informed targeting, psychoeducation, skills); (2) synchronized rTMS with modality- and network-matched psychotherapy delivered within post-stimulation plasticity windows; (3) consolidation/maintenance using skills practice, lifestyle supports, digital monitoring, and optional boosters; and (4) retreatment as indicated by clinical and biomarker criteria.
Conclusions: TAP is a tractable, testable model for coupling neuromodulation with psychotherapy. Feasibility is supported; rigorous trials must define optimal timing, targets, protocols, developmental trajectories, and comparative effectiveness.

Introduction
Transcranial-Magnetic-Stimulation–Assisted Psychotherapy (TAP) is a proposed general framework for structured, mechanism- and network-aligned treatment that couples repetitive TMS with concurrent or properly sequenced psychotherapy to leverage transient neuroplasticity for putative therapeutic learning and enhancement of developmental potential. TAP personalizes rTMS targeting and protocol (e.g., connectivity-guided excitatory or inhibitory stimulation) to the patient’s symptom network and aligns psychotherapy modality to the stimulated circuit’s cognitive–affective functions (e.g., cognitive restructuring with DLPFC/frontoparietal protocols; exposure/extinction and affect regulation with mPFC–limbic or salience-network–related protocols). In TAP, psychotherapy is foregrounded to highlight that longer-term growth and development as represented by psychotherapeutic processes tends to precede, continue during, and persist following TMS therapy. This is not a new idea, but worth developing. Implicit in the model, however, is that psychotherapy may also prime and enhance the effect of TMS, introducing various potential synergies which are as yet poorly understood and largely unresearched. Psychotherapy is itself a form of neuromodulation.

With a phase-based framework— starting with preparation and personalization, synchronized stimulation-plus-psychotherapy and/or meditation, consolidation and maintenance, and optional retreatment—TAP incorporates foundational skills (such as mindfulness), session-level process monitoring, and optional biomarker guidance (e.g., functional connectivity, hd-EEG) within established safety and training standards to improve efficacy, durability, scalability, and clinical outcomes. In addition, TAP can be generalized to include neuromodulation more broadly i.e. Neuromodulation-Assisted Psychotherapy (NAP). Ultimately, digital twins, dynamic causal modeling, neural geometrodynamics, established techniques, and emerging approaches leveraging AI may lead to fundamental discoveries.

At this time, there is little research or evidence-informed guidance, leaving much to the treatment team to determine with the patient, and outside providers if a collaborative framework is in place. Interdisciplinary care puts the patient first.

Transcending acute change, TAP aims to “bend the developmental curve,” aligning with lifespan models (e.g., Erikson) and psychodynamic concepts of internalization—helping therapeutic gains consolidate into more enduring patterns of relating, self-reflection, and adaptive functioning. The concept is straightforward yet transformative: use neuromodulation to open a “window of opportunity” when cognitive and emotional patterns are more malleable, then engage the patient in psychotherapy and supportive practices to consolidate lasting change (Brenner, February 2025; Brenner, June 2025). Notably, given that a subset of patients who have been depressed often for decades respond robustly in a short span of time with newer accelerated TMS protocols (ref), it is of particular importance to discuss this possibility in advance and work collaboratively with therapists to help them navigate adjusting to no longer being depressed.

Combined approaches are generally more effective than single modalities, but we still lack precise rules for how to combine and sequence them over developmental time; TAP offers a coherent, individualized process for doing so, allowing for a range of individually-tailored psychotherapeutic and meditation-based treatment courses. Furthermore, we need to better characterize the “post-stimulation plasticity window”, to determine the best timing of post-TMS therapeutic interventions, and whether therapeutic priming before TMS or during stimulation may have additional benefit.

Historical Background

Neuromodulation and TMS
Attempts at neuromodulation date back to antiquity, when electric fish were applied to relieve pain. By the 18th and 19th centuries, experimental bioelectricity laid groundwork for systematic interventions. rTMS emerged in the late 20th century as a noninvasive technique delivering repeated magnetic pulses to cortical regions, typically the dorsolateral prefrontal cortex (Li et al, 2022). Depending on frequency and protocol, rTMS can increase cortical excitability or reduce hyperactive circuits. Excitatory stimulation promotes synaptic potentiation, strengthening neural connections in underactive regions, while inhibitory stimulation can help quiet maladaptive networks. Mechanistically, TMS induces LTP-like plasticity and neurobiological changes (e.g. altering neurotransmitter activity, increasing Brain Derived Neurotrophic Factors BDNF and tropomyosin-related kinase receptor type B TrkB), and changes in information process and network activity directly related to stimulation, that may enhance learning and consolidation (Downar et al., 2024; Sharbafshaaer et al., 2024).

Beyond TMS, neuromodulation includes deep brain stimulation (DBS), vagus nerve stimulation (VNS), transcranial direct current stimulation (tDCS), cranial electrical stimulation (CES), neurophotobiomodulation, temporal interference, forms of neurofeedback, and transcranial focused ultrasound stimulation (tFUS). As network neuroscience advances, these tools may enable noninvasive “network surgery”—shifting dysconnectivity toward more adaptive “euconnectivity”—and support a gradual move from symptom-based diagnoses toward causal, network-based frameworks (Saxe et al., 2022; Kita et al., 2025)..

TMS and Psychotherapy
Psychotherapy has evolved from open-ended, theory-driven frameworks beginning with psychoanalysis, to a range of structured, more narrow therapist. Psychotherapy generally has a strong evidence base, regardless of the type, with debates over whether structured therapies really are superior to more traditional approaches given the available evidence showing that psychodynamic therapist are as effect near-term, and continue to have benefit after therapy has formally stopped (Leichsenring et al., 2023), presumably due to internalization of therapeutic processes leading to better self-directed psychological wellbeing. Cognitive Behavioral Therapy (CBT) focuses on restructuring maladaptive thoughts and behaviors; Dialectical Behavior Therapy (DBT) adapts CBT to chronic suicidality and borderline personality disorder with emphasis on acceptance and emotion regulation (Cohen, 2020). Psychodynamic therapy emphasizes insight, relational patterns, and unconscious processes, offering flexibility and depth. TAP is personalizable to adapt psychotherapeutic interventions to individual patients and treatment plans. Some patients may deepening psychodynamic insight and make new connections with reinvigorated capacity for reflection and connection, while others may lean in on making behavioral changes and looking at specific goals and outcomes.

Randomized and systematic evidence suggests that combining rTMS with psychotherapy and other non-pharmacological interventions yields promising but not definitive additive benefits. Donse and colleagues (2018) conducted a 6 months trial of rTMS plus CBT, and found higher response and remission rates with both together, compared with published outcomes for rTMS alone–however, there was no non-CBT control group. Large meta-analyses of long-term rTMS response predictors reveal that while factors such as concomitant medications have been studied, the role of other interventions with rTMS is typically not measured (e.g. Arici et al, 2022; Berlim et al., 2013). Another review (Kochanowski et al., 2024) found only 7 studies of rTMS plus therapy, showing the limited data available for formulating a coherent clinical approach.

A scoping review and meta-analysis reported large pretest–posttest effects for depressive symptom reduction with combined approaches such as aerobic exercise, bright light therapy, cognitive training, psychotherapy, sleep deprivation, or psychophysical tasks, concluding that controlled comparisons are lacking, suggesting promising results requiring further research (Giron et al., 2025). A Harvard Review of Psychiatry review found initial support for pairing TMS (and tDCS) with psychotherapy, including mindfulness-based interventions, while emphasizing the need for larger RCTs and standardized protocols (Kochanowski et al., 2024). A double-blind RCT demonstrated that concurrent rTMS and cognitive restructuring is feasible and may acutely enhance emotion regulation, though durable clinical gains require further study (Neacsiu et al., 2022). Overall, feasibility and mechanistic plausibility are supported; standardized timing/dose rules and larger, high-quality trials are needed.

Meditation appears to reduce DMN overactivity and strengthen attentional control, potentially extending the impact of neuroplastic windows (Menon, 2023; Kabat-Zinn, 2025). Given that MRI guided TMS, as noted above in recent research, is also linked with reduced DMN activity, it makes sense but remains untested whether such practices can prolong or even deepen the response. Adjunctive lifestyle strategies (structured exercise, morning light, social engagement, sleep hygiene) show preliminary signals of additive benefit with neuromodulation, though evidence certainty is low to moderate and formal guidelines are lacking (Giron et al., 2025; Rosson et al., 2022). Without frameworks to translate circuit changes into habits, rTMS benefits may dissipate prematurely (Brenner, June 2025; Tirrell et al., 2020). Interestingly, fMRI guided TMS for clinical depression has been shown to influence default mode network (DMN) and dorsal attention network (DAN) activity, associated with standard navigated sgACC targets but with suggested better reliability for targeting based on resting state network mapping (RSNM) using machine learning analysis (Siddiqi et al., 2023).

Conceptual Rationale for TAP

Treatment Resistance and Personalization
Treatment resistance is not patient failure; it reflects the complexity of human neurobiology and psychology, and the lack of both more effective, accessible treatments, and personalize, thoughtful and comprehensive evaluation and treatment planning. Financial factors undermine this, as when reimbursement or self-pay resources are insufficient to support needed care. When patients do not respond to a single intervention, it indicates a need for a closer look, and re-assessment. TAP embodies this principle, tailoring interventions dynamically rather than applying static protocols.

From Symptom Categories to Network Alignment
Large-scale brain network perspectives offer a practical scaffold for TAP. The “Big 3”(tripartite model) is useful, though incomplete. It includes the central executive/frontoparietal network (CEN/FPN), default mode network (DMN), and salience network (SN) (Menon, 2011; Menon, 2023). The SN helps switch between internally oriented DMN and externally oriented (CEN) modes. In practice, TAP aligns psychotherapy content with network targets: cognitive control and reappraisal with CEN upregulation; rumination, self-referential processing, and identity work with DMN normalization; interoception, threat/safety learning, and attention reorienting with SN calibration. For OCD, CSTC loop targeting aligns with exposure/response prevention. This network framing supports an eventual move toward causal, network-based diagnostics and individualized protocols.

Barriers in Current Mental Health Care

Mental health care remains hindered by stigma, inconsistent screening, limited follow-up, and fragmentation between biological and psychosocial approaches. Standard tools such as the PHQ-9, GAD-7, and MDQ are valid but patients may be partially adherent with using them (Odero et al., 2025; Waheed et al., 2024; Smith et al., 2024). Abbreviated forms might maintain reliability and improve adherence (Smith et al., 2024). TAP suggests embedding these assessments within a complete clinical ecosystem so that neuromodulation and psychotherapy are guided by continuous, patient-centered care with regular monitoring and updating, rather than a one-and-done approach to prescription without the broader context.

TAP Model and Phases of Care

Pretreatment
Patients should maintain stable pharmacological regimens to preserve neurochemical baselines and motor thresholds prior to acute phase TMS therapy, unless there is a strong clinical indication. This is more feasible with accelerated protocols versus standard TMS due to the shorter time window of one week, versus several weeks, respectively. Incorporating structured mindfulness exercises before treatment may prepare patients in a calm, receptive state, reducing rigidity and fostering neuroplastic readiness (Fleming, 2023). Lifestyle priming (sleep regularity, morning light exposure, and moderate aerobic activity) may further tune arousal and learning systems, although guideline-level recommendations for routine combination with TMS are not yet established and evidence certainty is low to moderate (Rosson et al., 2022).

Personalization and treatment planning are critical during the pretreatment phase. MRI guided TMS may be more effective for specific patients and conditions, for example (references) and regardless careful assessment and planning for the TMS protocol are critically important. Patients with co-morbid conditions may benefit from treatment of more than one area, with MDD the primary target and OCD, for example, a secondary synergistic target. While MRI guidance may be a barrier to treatment due to cost and inconvenience, targeting with EEG and emerging technologies such as functional near infrared spectroscopy (fNIRS) may streamline the process, reducing cost and improving accessibility.

Likewise, the approach to psychotherapy and lifestyle changes should be assessed and modified if appropriate with consideration for both the TMS treatment, as well as anticipated changes extending beyond the acute TMS treatment. Interdisciplinary coordination is critical during the treatment planning, and requires additional time for team meetings and motivating patients to adhere to a more robust program designed to take advantage of the TMS window of opportunity and maximize impact beyond the effect of TMS alone.

Future developments could also include the use of artificial intelligence and digital twin technology to model an optimal treatment intervention personalized to individual patients, based on rich data sets including functional brain analysis, clinical assessment, data from wearables, and related information traditionally difficult to analyze and integrate. Recent studies (2023, 2025) and accruing data already have demonstrated that machine learning can, for instance using SVM??? Or alzheimers (support vector machines) be used to develop targeting based on resting state network mapping from fMRI finding stronger associations with treatment response and dorsal attention network (DAN) and default mode network (DMN), related to but more effective than recent subgenual ACC (sgACC)-based targets. A forthcoming study (preprint) found that response rates for MRI guided accelerated TMS were significantly higher than without, 7X% vs 64X% (ref). It remains unclear if and when precision TMS (pTMS?) will become standard of care, and for whom it will be indicated.

Treatment Phase
During rTMS, psychotherapy sessions might enhance TMS response, and TMS in turn may increase the impact of psychotherapeutic interventions. However, there is limited data on what type of therapy would work best for whom, under various circumstances. Speculatively, it may be that more concrete interventions, including behavioral and cognitive behavior approaches focusing on behavioral activation and lifestyle, may be more useful near-term for patients whose basic routines and self-care are impaired. Interventions leveraging neuroplasticity, such as self-compassion based practices, have been shown to be effective in MDD, anxiety and post-traumatic conditions, and may also be useful if receptivity is enhanced during and after acute TMS–given that self-care is often impaired in those with such chronic conditions, and is a key factor in growth and recovery.

TAP views rTMS not as a replacement, rather a catalyst for psychotherapy—analogous to surgery requiring thoughtful, sequence rehabilitation. Anecdotally, in this author’s experience, some patients appear vulnerable to relapse after TMS, for example those with comorbid personality disorders who engage in self-defeating behaviors, pursue against medical advice relationally stressful events such unfortunate romantic engagements. Anecdotally, in other situations, patients with comorbid trauma may work with therapists who want to do exposure therapy right away–while some do well, others find it too stressful, and the advice in those cases is to focus on routines and lifestyle changes, leaving the more challenging work for a future date–other with downstream benefit. Others find that TMS leaves them immediately in a position to tackle more difficult challenges. At this time, clinical experience and judgement provide more guidance on treatment planning than the evidence base.

Research suggests TMS may enhance engagement with psychotherapeutic interventions in less adherent patients. For example, patients receiving left or right DLPFC rTMS were found to have better self-regulation, and those receiving left-sided rTMS were more likely to utilize cognitive restructuring, and reported less distress during and following rTMS, versus those who received sham (Neacsiu et al., 2022). Mindfulness-consistent cueing can support attentional control; however, feasibility studies highlight practical constraints—depressed patients in a feasibility study of mindfulness-based cognitive therapy had high dropout rates as the sound of rTMS confounded in-session practice (Cavallero et al., 2021). This highlights the importance of better understanding the timing of interventions relative to rTMS, as well as developing interventions which can be deployed, if found to be effective, during sessions.

Post-Treatment (Consolidation and Maintenance)
After rTMS, ideally and with personalized and reinforced programming, patients continue to show gains both as a direct effect of the intervention, and synergistically with psychotherapeutic and concrete practices such as lifestyle modification and, for some, meditative work. Research suggests that gains from TMS extend beyond the acute treatment phase (e.g. Arici et al., 2022; Luehr et al., 2024). These enduring effects should be deepened, and further researched to understand how to best make use of them, rather than simply monitoring for the need for re-treatment.

Extending the surgical procedure metaphor to TMS, a rotator cuff repair surgery may reapproximate the anatomy of a functional shoulder and restore basic immediate function, but in the post-operative period, rehabilitation is graded to avoid overexertion and re-injury, and improve longer term recovery, strength and function, over a period of months.

Retreatment/Booster Phase (Optional)
A fourth, optional phase involves retreatment or booster sessions triggered by clinical relapse, biomarker drift (e.g., target network connectivity), or developmental/life-stage transitions. Retreatment follows the same personalized, network- and modality-matched principles, with emphasis on rapid reconsolidation of skills and habits.

Interdisciplinary collaboration is important as therapists and outside psychiatrists should be informed as to what to look for in order to recommend retreatment, in addition to patient education and the use of post-treatment patient self-report scales, as patients are often discharged after the acute TMS treatment, similar to other procedural specialties, to the care of their primary clinicians. As adherence is often low with follow-up monitoring, even with monthly push notifications, collaborative care remains the best way to ensure proper post-treatment monitoring.

Innovations and Expanding Applications

Meditation as a Neuroplasticity Primer
Meditative practices complement rTMS by stabilizing attention and reducing self-criticism. Mindfulness fosters non-reactive awareness; transcendental practices induce relaxation via mantra repetition; loving-kindness cultivates positive affect (Kabat-Zinn, 2025). Reviews of neuromodulation and meditation suggest that non-invasive brain stimulation may augment neural and behavioral effects of meditation, but heterogeneity and small samples limit firm conclusions (Abellaneda-Pérez et al., 2024). When paired with TMS, meditation may extend the “window of opportunity,” suppressing maladaptive DMN activity and reinforcing more adaptive states. Practical constraints during active stimulation warrant scheduling meditation before or immediately after sessions for many patients (Cavallero et al., 2021).
[Comment: Add brief operational guidance: 5–10 minutes pre-session breath-focused mindfulness; 10–15 minutes post-session loving-kindness or values-consistent reflection; weekly progression plan.]

Neurotechnological Personalization
AI and advanced neuroimaging enable individualized network maps and real-time monitoring. Machine learning can derive connectivity-informed targets; neuronavigation-guided, multi-locus TMS allows electronically adjustable, spatially precise delivery; and hd-EEG provides neurophysiological feedback on circuit engagement (Lioumis, 2025). Dynamic causal modeling (DCM) clarifies how stimulation propagates through networks, supporting a shift toward causal, circuit-based treatment (Brenner, 2025). Looking ahead, digital twinning and complex systems modeling may integrate brain, body, and social data to simulate individualized TAP courses and optimize sequencing (Capra, 1996; Dwyer et al., 2018). These tools promise precision but require validation in large, controlled trials.

Example: Language and Cognitive Rehabilitation
TAP principles extend beyond mood and anxiety disorders. In primary progressive aphasia, combining intermittent theta-burst TMS with language therapy improved lexical retrieval and naming at three months with stability at six months, while sham declined; daily functioning and neuropsychiatric symptoms also improved (Fernández-Romero et al., 2025). This is an exemplar of how neuromodulation-assisted therapy may be applied in neurological and psychiatric conditions.

Discussion

TAP may represent a paradigm shift in how we conceptualize integrated neuromodulation-based therapeutics, though experienced practitioners recognize the important role of interventions around rTMS. Rather than treating biological and psychological interventions as separate or sequential, TAP proposes thoughtful evaluation and treatment planning to optimize synergistic effects, while also recognizing the critical need for more robust research. At the same time, TAP is consistent with the standard biopsychosocial model of medical care, correcting for increasing fragmentation and reductionism in mental healthcare systems and care frameworks.

Meta-analytic and systematic reviews indicate that rTMS combined with psychotherapy and other non-pharmacological methods is feasible and may yield additional benefits, though additive effects over rTMS alone are modest and inconsistently demonstrated, with circumscribed methodological quality limited clinical application (Giron et al., 2025; Kochanowski et al., 2024; Neacsiu et al., 2022). For meditation pairings, feasibility challenges and limited data likewise constrain clinical conclusions (Cavallero et al., 2021; Abellaneda-Pérez et al., 2024). Furthermore, for a significant percent of people (8-10 %), mindfulness meditation may worsen symptoms of anxiety, depression, traumatic reactions, emotional sensitivity and cognitive problems (e.g. Farais et al., 2020; Goldberg et al., 2023).

Lifestyle adjuncts such as exercise and light therapy show preliminary promise and have been shown to enhance plasticity and mental wellbeing on their own (e.g. Philips, 2017). There is minimal data on combining rTMS and lifestyle modifications, though experts suggest there may be efficacy and recommend further study (Hendrikse et al., 2017). In parallel, observational real-world reports for TRD describe high response and remission rates for TMS—particularly within integrated care settings—offering hypothesis-generating signals for effectiveness and implementation (e.g., Levkovitz et al., 2023; Cole et al., 2023), yet these require confirmation in randomized and hybrid trials.

Broader neuromodulation perspective: Beyond TMS, non-invasive brain stimulation modalities (e.g., tDCS, patterned TMS/TBS) show transdiagnostic efficacy signals across psychiatric conditions (Hyde et al., 2022). As network neuroscience matures, neuromodulation may increasingly function as noninvasive “network surgery,” shifting dysconnectivity toward euconnectivity and supporting a network-based diagnostic model. TAP’s logic—matching psychotherapy content to targeted circuits and delivering it within biologically active windows—generalizes across neuromodulatory tools.

Longer-term developmental change: While TAP emphasizes short-term timing-dependent interactions, TMS induces synaptic and network-level plasticity with age- and disease-dependent dynamics (Fitzsimmons et al., 2024; Oberman & Benussi, 2024). This supports the hypothesis that synchronized stimulation-plus-therapy could recalibrate trajectories—not only relieving symptoms but promoting durable internalization and growth. Direct evidence for long-arc developmental change due to combined therapy remains limited and largely theoretical (Vaishnavi, 2023); longitudinal studies with repeated network phenotyping are needed to test trajectory shifts across developmental stages and degenerative conditions.

The model highlights three broader implications:

• Personalized Psychiatry: By linking neuromodulation with psychotherapy, TAP aligns with precision-medicine goals. Circuit-informed target selection, network mapping (CEN/DMN/SN; CSTC for OCD), and modality matching may improve signal-to-noise and durability.
• Integration Across Systems: Embedding TAP into routine care requires dismantling silos between psychiatry, psychology, neurology, and rehabilitation, with shared protocols, outcomes, and training standards. TAP also stands within a lineage of assisted-psychotherapy models (e.g., ketamine-, psychedelic-assisted therapy), adapted to the distinct mechanisms of TMS.
• Preventive and Rehabilitative Potential: Evidence from PPA suggests TAP may preserve function and quality of life in neurodegenerative illness, extending beyond psychiatry into cognitive rehabilitation; developmental applications warrant careful, staged study.

Conclusion

TAP is not a stand-alone treatment but a structured framework for integrating rTMS and psychotherapy. It leverages neuromodulation to prime the brain for change and psychotherapy to guide that change toward enduring growth, with meditation and lifestyle strategies supporting consolidation. AI, fMRI/DCM, hd-EEG, and potentially digital twinning expand personalization and planning. Current evidence supports feasibility and mechanistic plausibility, with early signals of additive benefit; rigorous trials must define optimal timing, targets, protocols, and long-term developmental impacts. TAP represents a paradigm shift—bridging symptom categories and network-informed, developmentally oriented care—to synchronize treatments for sustainable change.

References

Li, J., Cui, L., & Li, H. (2022). Optimal parameter determination of repetitive transcranial magnetic stimulation for treating treatment-resistant depression: A network meta-analysis of randomized controlled trials. Frontiers in Psychiatry, 13, 1038312. https://doi.org/10.3389/fpsyt.2022.1038312

Downar, J., Siddiqi, S. H., Mitra, A., Williams, N., & Liston, C. (2024). Mechanisms of action of TMS in the treatment of depression. In M. Browning, P. J. Cowen, & T. Sharp (Eds.), Emerging neurobiology of antidepressant treatments (pp. 1–28). Springer.

Sharbafshaaer, M., Cirillo, G., Esposito, F., Tedeschi, G., & Trojsi, F. (2024). Harnessing brain plasticity: The therapeutic power of repetitive transcranial magnetic stimulation (rTMS) and theta burst stimulation (TBS) in neurotransmitter modulation, receptor dynamics, and neuroimaging for neurological innovations. Biomedicines. https://pmc.ncbi.nlm.nih.gov/articles/PMC11592033/

Saxe, G. N., Bickman, L., Ma, S., & Aliferis, C. (2022). Mental health progress requires causal diagnostic nosology and scalable causal discovery. Frontiers in Psychiatry, 13, 898789. https://doi.org/10.3389/fpsyt.2022.898789

Kita, A., Ishida, T., Kita, N., et al. (2025). Exploring the capabilities of repetitive transcranial magnetic stimulation in major depressive disorder: Dynamic causal modeling of the neural network. Translational Psychiatry, 15, 257. https://doi.org/10.1038/s41398-025-03480-7

Leichsenring, F., Abbass, A., Heim, N., Keefe, J. R., Kisely, S., Luyten, P., Rabung, S., & Steinert, C. (2023). The status of psychodynamic psychotherapy as an empirically supported treatment for common mental disorders - an umbrella review based on updated criteria. World Psychiatry, 22(2), 286-304. https://doi.org/10.1002/wps.21104

Cohen. (2020, May 20). Five different approaches to therapy. Columbia University Department of Psychiatry. https://www.columbiapsychiatry.org/news/five-different-approaches-therapy

Donse, L., Padberg, F., Sack, A. T., Rush, A. J., & Arns, M. (2018). Simultaneous rTMS and psychotherapy in major depressive disorder: Clinical outcomes and predictors from a large naturalistic study. Brain Stimulation, 11(2), 337–345. https://doi.org/10.1016/j.brs.2017.11.004

Arici, C., Benatti, B., Cafaro, R., Cremaschi, L., Degoni, L., Pozzoli, S., Oldani, L., Molteni, L., Giorgetti, F., Priori, A., Viganò, C., & Dell'Osso, B. (2022). A 6-month follow-up study on response and relapse rates following an acute trial of repetitive transcranial magnetic stimulation in patients with major depression. CNS Spectrums, 27(1), 93-98. https://doi.org/10.1017/S1092852920001807

Berlim, M. T., van den Eynde, F., Tovar-Perdomo, S., & Daskalakis, Z. J. (2014). Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychological Medicine, 44(2), 225-239. https://doi.org/10.1017/S0033291713000512

Kochanowski, B., Kageki-Bonnert, K., Pinkerton, E. A., Dougherty, D. D., & Chou, T. (2024). A review of transcranial magnetic stimulation and transcranial direct current stimulation combined with medication and psychotherapy for depression. Harvard Review of Psychiatry, 32(3), 77–95. https://doi.org/10.1097/HRP.0000000000000396

Giron, C. G., Tang, A. H. P., Jin, M., & Kranz, G. S. (2025). Antidepressant efficacy of administering repetitive transcranial magnetic stimulation (rTMS) with psychological and other non-pharmacological methods: A scoping review and meta-analysis. Psychological Medicine, 55, e64. https://doi.org/10.1017/S0033291725000315

Neacsiu, A. D., Beynel, L., Powers, J. P., et al. (2022). Enhancing cognitive restructuring with concurrent repetitive transcranial magnetic stimulation: A transdiagnostic randomized controlled trial. Psychotherapy and Psychosomatics, 91(2), 94–106. https://doi.org/10.1159/000518957

Menon, V. (2023). 20 years of the default mode network: A review and synthesis. Neuron, 111(16), 2469–2487. https://doi.org/10.1016/j.neuron.2023.04.023

Kabat-Zinn, J. (2025, April 24). This loving-kindness meditation is a radical act of love. Mindful. https://www.mindful.org/this-loving-kindness-meditation-is-a-radical-act-of-love/

Rosson, S., de Filippis, R., Croatto, G., et al. (2022). Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review. Neuroscience and Biobehavioral Reviews, 139, 104743. https://doi.org/10.1016/j.neubiorev.2022.104743

Brenner. (2025, June 26). TMS-assisted psychotherapy: Moving toward a paradigm shift. Psychology Today. https://www.psychologytoday.com/us/blog/experimentations/202505/tms-assisted-psychotherapy-moving-toward-a-paradigm-shift

Tirrell, E., Cavallero, F., Kokdere, G., Gold, M., Donachie, S., Steinfink, D., Kriske, J., & Carpenter, L. (2020). Audio-guided mindfulness meditation during TMS sessions for the treatment of major depressive disorder (MDD): A feasibility pilot study. Brain Stimulation. https://www.brainstimjrnl.com/article/S1935-861X%2820%2930149-2/fulltext

Siddiqi, S. H., Kandala, S., Hacker, C. D., Trapp, N. T., Leuthardt, E. C., Carter, A. R., & Brody, D. L. (2023). Individualized precision targeting of dorsal attention and default mode networks with rTMS in traumatic brain injury-associated depression. Scientific Reports, 13(1), 4052. https://doi.org/10.1038/s41598-022-21905-x

Menon, V. (2011). Large-scale brain networks and psychopathology: A unifying triple network model. Trends in Cognitive Sciences, 15(10), 483–506.

Odero, S. A., Mwangi, P., Odhiambo, R., et al. (2025). Psychometric evaluation of PHQ–9 and GAD–7 among community health volunteers and nurses/midwives in Kenya following a nation-wide telephonic survey. Frontiers in Psychiatry. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1123839/full

Waheed, A., Afridi, A. K., Rana, M., et al. (2024). Knowledge and behavior of primary care physicians regarding utilization of standardized tools in screening and assessment of anxiety, depression, and mood disorders at a large integrated health system. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319231224711

Smith, K., Knapstad, M., & Aarø, L. E. (2024, December 26). Minimizing patient burden in outcome monitoring: The case for abbreviated versions of PHQ-9, GAD-7 and WSAS. Journal of Affective Disorders. https://www.sciencedirect.com/science/article/pii/S0165032724020767

Fleming [Note: Citation appears as "(Fleming, 2023)" but full reference is not provided in reference list]

Cavallero, F., Gold, M. C., Tirrell, E., et al. (2021). Audio-guided mindfulness meditation during transcranial magnetic stimulation sessions for the treatment of major depressive disorder: A pilot feasibility study. Frontiers in Psychology, 12, 678911. https://doi.org/10.3389/fpsyg.2021.678911

Luehr, J. G., & Sackeim, H. A., et al. (2024). Accelerated transcranial magnetic stimulation: A pilot study of safety and efficacy using a pragmatic protocol. Brain Stimulation, 17(4), 860–863. https://doi.org/10.1016/j.brs.2024.03.007

Abellaneda-Pérez, K., Potash, R. M., Pascual-Leone, A., & Sacchet, M. D. (2024). Neuromodulation and meditation: A review and synthesis toward promoting well-being and understanding consciousness and brain. Neuroscience and Biobehavioral Reviews, 166, 105862. https://doi.org/10.1016/j.neubiorev.2024.105862

Brenner. (2025, August 3). Dynamic causal modeling advances TMS therapy for depression. Psychology Today. https://www.psychologytoday.com/us/blog/experimentations/202507/dynamic-causal-modeling-advances-tms-therapy-for-depression

Capra, F. (1996). [Note: Citation appears but full reference is not provided in reference list]

Dwyer et al., 2018 [Note: Citation appears but full reference is not provided in reference list]

Fernández-Romero, L., Cabrera-Martin, M. N., Delgado-Alonso, C., et al. (2025). Long-term therapy with transcranial magnetic stimulation in primary progressive aphasia: A randomized clinical trial. JAMA Network Open, 8(8), e2526129. https://doi.org/10.1001/jamanetworkopen.2025.26129

Farias, M., Maraldi, E., Wallenkampf, K. C., & Lucchetti, G. (2020). Adverse events in meditation practices and meditation-based therapies: a systematic review. Acta Psychiatrica Scandinavica, 142(5), 374-393. https://doi.org/10.1111/acps.13225

Goldberg, S. B., Lam, S. U., Britton, W. B., & Davidson, R. J. (2022). Prevalence of meditation-related adverse effects in a population-based sample in the United States. Psychotherapy Research, 32(3), 291-305. https://doi.org/10.1080/10503307.2021.1933646

Phillips, C. (2017). Lifestyle modulators of neuroplasticity: How physical activity, mental engagement, and diet promote cognitive health during aging. Neural Plasticity, 2017, 3589271. https://doi.org/10.1155/2017/3589271

Hendrikse, J., Kandola, A., Coxon, J., Rogasch, N., & Yücel, M. (2017). Combining aerobic exercise and repetitive transcranial magnetic stimulation to improve brain function in health and disease. Neuroscience & Biobehavioral Reviews, 83, 11–20. https://doi.org/10.1016/j.neubiorev.2017.09.023

Levkovitz, Y., et al. (2023). Post-marketing analysis of deep TMS for treatment-resistant depression: Response and remission rates in a real-world cohort. Brain Stimulation, 16(2), 345–352.

Cole, E. J., et al. (2023). Real-world effectiveness of transcranial magnetic stimulation for depression: Outcomes from a large academic center. Journal of Affective Disorders, 335, 234–241.

Hyde, J., Carr, H., Kelley, N., et al. (2022). Efficacy of neurostimulation across mental disorders: Systematic review and meta-analysis of 208 randomized controlled trials. Molecular Psychiatry, 27(6), 2709–2719. https://doi.org/10.1038/s41380-022-01524-8

Fitzsimmons, S. M. D. D., Oostra, E., Postma, T. S., van der Werf, Y. D., & van den Heuvel, O. A. (2024). Repetitive transcranial magnetic stimulation-induced neuroplasticity and the treatment of psychiatric disorders: State of the evidence and future opportunities. Biological Psychiatry, 95(6), 592–600. https://doi.org/10.1016/j.biopsych.2023.11.016

Oberman, L. M., & Benussi, A. (2024). Transcranial magnetic stimulation across the lifespan: Impact of developmental and degenerative processes. Biological Psychiatry, 95(6), 581–591. https://doi.org/10.1016/j.biopsych.2023.07.012

Vaishnavi, 2023 [Note: Citation appears but full reference is not provided in reference list]

Brenner. (2025, February 3). Revisioning mental disorder causation to improve treatments. Psychology Today. https://www.psychologytoday.com/us/blog/experimentations/202502/revisioning-mental-disorder-causation-to-improve-treatments

Lioumis, P., et al. (2025). Optimization of TMS target engagement: Current state and future perspectives. Frontiers in Neuroscience, 19. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2025.1517228/full

Zheng, A., Yu, R., Du, W., et al. (2020). Two-week rTMS-induced neuroimaging changes measured with fMRI in depression. Journal of Affective Disorders, 270, 15–21. https://doi.org/10.1016/j.jad.2020.03.038

Note: Three citations appear in the text but lack complete references in the reference list: Fleming (2023), Capra (1996), Dwyer et al. (2018), Vaishnavi (2023)

Read this next

---

---